Humanwell Healthcare Group Co Ltd Total Liabilities
Humanwell Healthcare Group Co Ltd total liabilities. Based on the latest financial reports, Humanwell Healthcare Group Co Ltd (600079) has total liabilities worth CN¥14.75 Billion CNY (≈ $2.16 Billion USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Humanwell Healthcare Group Co Ltd (600079) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Humanwell Healthcare Group Co Ltd (1994–2025)
Total liabilities of Humanwell Healthcare Group Co Ltd from 1994 to 2025. This chart illustrates how Humanwell Healthcare Group Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore Humanwell Healthcare Group Co Ltd long-term investment intensity to see how much of total assets are deployed in long-term investments.
Humanwell Healthcare Group Co Ltd Competitors by Total Liabilities
The table below lists competitors of Humanwell Healthcare Group Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Iridium Communications Inc
NASDAQ:IRDM
|
USA | $2.09 Billion |
|
FLSmidth & Co.
CO:FLS
|
Denmark | Dkr12.38 Billion |
|
Zhejiang Hailiang Co Ltd
SHE:002203
|
China | CN¥34.65 Billion |
|
BillionToOne, Inc. Class A Common Stock
NASDAQ:BLLN
|
USA | $192.89 Million |
|
Piper Sandler Companies
NYSE:PIPR
|
USA | $759.43 Million |
|
Xian Sunresin New Materials Co Ltd
SHE:300487
|
China | CN¥2.13 Billion |
|
COCHLEAR LTD ADR 1/2/O.N.
F:OC50
|
Germany | €874.70 Million |
|
Insight Enterprises Inc
NASDAQ:NSIT
|
USA | $9.79 Billion |
Liability Composition Analysis (1994–2025)
This chart breaks down Humanwell Healthcare Group Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Humanwell Healthcare Group Co Ltd asset portfolio.
Liquidity & Leverage Metrics
Humanwell Healthcare Group Co Ltd Total Liabilities Ratios Explained
Humanwell Healthcare Group Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.94 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.76 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.40 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Humanwell Healthcare Group Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Humanwell Healthcare Group Co Ltd (1994–2025)
The table below shows the annual total liabilities of Humanwell Healthcare Group Co Ltd from 1994 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥14.74 Billion ≈ $2.16 Billion |
-6.81% |
| 2024-12-31 | CN¥15.82 Billion ≈ $2.31 Billion |
-1.80% |
| 2023-12-31 | CN¥16.11 Billion ≈ $2.36 Billion |
-10.92% |
| 2022-12-31 | CN¥18.08 Billion ≈ $2.65 Billion |
-8.47% |
| 2021-12-31 | CN¥19.75 Billion ≈ $2.89 Billion |
+1.64% |
| 2020-12-31 | CN¥19.44 Billion ≈ $2.84 Billion |
-10.94% |
| 2019-12-31 | CN¥21.82 Billion ≈ $3.19 Billion |
+0.57% |
| 2018-12-31 | CN¥21.70 Billion ≈ $3.18 Billion |
+11.71% |
| 2017-12-31 | CN¥19.43 Billion ≈ $2.84 Billion |
+34.48% |
| 2016-12-31 | CN¥14.45 Billion ≈ $2.11 Billion |
+61.04% |
| 2015-12-31 | CN¥8.97 Billion ≈ $1.31 Billion |
+39.30% |
| 2014-12-31 | CN¥6.44 Billion ≈ $942.28 Million |
+39.18% |
| 2013-12-31 | CN¥4.63 Billion ≈ $677.03 Million |
+9.85% |
| 2012-12-31 | CN¥4.21 Billion ≈ $616.30 Million |
+38.93% |
| 2011-12-31 | CN¥3.03 Billion ≈ $443.59 Million |
+59.49% |
| 2010-12-31 | CN¥1.90 Billion ≈ $278.12 Million |
+54.87% |
| 2009-12-31 | CN¥1.23 Billion ≈ $179.58 Million |
-6.61% |
| 2008-12-31 | CN¥1.31 Billion ≈ $192.30 Million |
+5.13% |
| 2007-12-31 | CN¥1.25 Billion ≈ $182.91 Million |
+4.88% |
| 2006-12-31 | CN¥1.19 Billion ≈ $174.40 Million |
-6.60% |
| 2005-12-31 | CN¥1.28 Billion ≈ $186.72 Million |
+15.97% |
| 2004-12-31 | CN¥1.10 Billion ≈ $161.00 Million |
+9.51% |
| 2003-12-31 | CN¥1.00 Billion ≈ $147.02 Million |
+34.99% |
| 2002-12-31 | CN¥744.27 Million ≈ $108.91 Million |
+25.15% |
| 2001-12-31 | CN¥594.72 Million ≈ $87.03 Million |
+208.11% |
| 2000-12-31 | CN¥193.03 Million ≈ $28.25 Million |
+6.85% |
| 1999-12-31 | CN¥180.65 Million ≈ $26.44 Million |
+14.21% |
| 1998-12-31 | CN¥158.17 Million ≈ $23.15 Million |
+76.93% |
| 1997-12-31 | CN¥89.40 Million ≈ $13.08 Million |
+3.52% |
| 1996-12-31 | CN¥86.36 Million ≈ $12.64 Million |
+55.32% |
| 1995-12-31 | CN¥55.60 Million ≈ $8.14 Million |
+11.27% |
| 1994-12-31 | CN¥49.97 Million ≈ $7.31 Million |
-- |
About Humanwell Healthcare Group Co Ltd
Humanwell Healthcare (Group) Co.,Ltd. researches, develops, produces, and sells pharmaceutical products in China and internationally. The company offers sufentanil citrate injection, an analgesic drug for combined anesthesia; remifentanil hydrochloride injection for induction of general anesthesia and maintenance of analgesia during general anesthesia; hydromorphone hydrochloride injection for pa… Read more